CPMV — Mosaic ImmunoEngineering Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 836564 ·
Last close
$0.69
Market Cap
$5.03M
52W High
$0.75
52W Low
$0.33
ADV30
257
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -154,802 | -175,351 | 9,828 | 72 | 7,661,199 |
| Dec 2025 | 0 | — | -148,133 | -169,137 | 19,882 | 3,622 | 7,495,902 |
| Sep 2025 | 0 | — | -144,358 | -165,361 | 55,298 | 31,761 | 7,362,181 |
| Jun 2025 | 0 | — | -148,854 | -172,028 | 57,699 | 53,583 | 7,199,221 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-111,397
Investing CF
$0
Financing CF
$145,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.10
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,526,166
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-602,113
Pretax Income TTM
$-685,446
Interest Exp TTM
$83,333
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -616,119 | -687,846 | 19,882 | 7,495,902 | — | -111,397 |
| Dec 2024 | 0 | -879,655 | -921,983 | 141,611 | 6,929,785 | — | -241,159 |
| Dec 2023 | 0 | -1,399,768 | -1,008,235 | 179,533 | 6,050,591 | — | -497,467 |
| Dec 2022 | 0 | -2,627,522 | -2,380,870 | 261,277 | 5,146,035 | — | -690,129 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| APTOF | Aptose Biosciences Inc. | $4.29M | $1.68 | — |
| BCAB | BioAtla, Inc. | $6.48M | $3.91 | — |
| VIVS | VivoSim Labs, INC. | $3.73M | $1.29 | — |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | $6.95M | $0.63 | — |
| LIMN | Liminatus Pharma, Inc. | $7.36M | $0.16 | — |
Recent Insider Activity
No insider activity indexed for this ticker.